Drug firm Alembic Pharma on Wednesday said it has received approval from the US health regulator for Fenofibrate capsules, which reduces cholesterol and triglycerides in blood. The approved product is therapeutically equivalent to the reference listed drug product Tricor Micronized Capsules of AbbVie Inc.To Contact Insurance and Investment Expert
Thanks for reading. Please Share, Comment, Like the post And Follow, Subscribe Insurance and Investment News
from Source
Alembic Pharma gets USFDA nod for cholesterol lowering drug
Reviewed by Insurance Advisor
on
October 21, 2020
Rating:
No comments: